Daniel C. Javitt - 10%+ Owner at NRX Pharmaceuticals, Inc.

Issuer-level insider activity

Role
10%+ Owner
Issuer ticker
NRXP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Daniel C. Javitt since 20 Sep 2025

Reported holdings for Daniel C. Javitt in NRX Pharmaceuticals, Inc.

Form 4 holding 10%+ Owner

NRX Pharmaceuticals, Inc.

Security class
common stock
Shares / value
9,634,793
Estimated value
$3,082,170
Report date
30 Nov 2022
Price
$0.3199
Ownership
by Glytech LLC

Transaction history for Daniel C. Javitt in NRX Pharmaceuticals, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .